MedTrace Logo

Study to Evaluate Novel Gastric Space Occupying Device

NCT01288456 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2012-05-28

No results posted yet for this study

Summary

This will be an observational, prospective, non-randomized, pilot study to gain initial device experience on a novel space-occupying device in persons who are overweight or obese. No formal hypothesis testing will be conducted.

Conditions

Sponsors & Collaborators

  • Obalon Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Ariel Ortiz, MD · Obesity Control Center

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-02-28
Completion
2011-03-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01288456 on ClinicalTrials.gov